Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Chemmedchem
|
March 7, 2007
A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?
Isabella Berger, Alexey A Nazarov, Christian G Hartinger, et al.
Journal of Medicinal Chemistry
|
March 5, 2011
Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA
Filipa Mendes, Michael Groessl, Alexey A Nazarov, et al.
Journal of Diabetes Science and Technology
|
September 30, 2021
Effects of Aerobic Exercise on Systemic Insulin Degludec Concentrations in People with Type 1 Diabetes
David Herzig, Michael Groessl, Mario Álvarez-Martínez, et al.
Analytical Chemistry
|
August 24, 2019
Quantitative Fragmentation Model for Bottom-Up Shotgun Lipidomics
Kai Schuhmann, HongKee Moon, Henrik Thomas, et al.
Eclinicalmedicine
|
April 15, 2024
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial
Paolo Mulatero, Gregoire Wuerzner, Michael Groessl, et al.
Scientific Reports
|
May 7, 2021
Steroid hormone bioavailability is controlled by the lymphatic system
Rahel Klossner, Michael Groessl, Nadine Schumacher, et al.
Molecular & Cellular Proteomics : MCP
|
April 25, 2025
Landscape of Steroid Dynamics in Pregnancy: Insights From the Maternal-Placental-Fetal Unit and Placental Models
Rona Karahoda, Therina Du Toit, Barbara Fuenzalida, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 16, 2011
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine
Oliver Brandt, Michael Mildner, Alexander E Egger, et al.
Journal of Medicinal Chemistry
|
April 4, 2007
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity
Michael Groessl, Erwin Reisner, Christian G Hartinger, et al.
Chemistry & Biodiversity
|
October 31, 2008
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients
Christian G Hartinger, Michael A Jakupec, Stefanie Zorbas-Seifried, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Chemmedchem
|
March 7, 2007
A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?
Isabella Berger, Alexey A Nazarov, Christian G Hartinger, et al.
Journal of Medicinal Chemistry
|
March 5, 2011
Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA
Filipa Mendes, Michael Groessl, Alexey A Nazarov, et al.
Journal of Diabetes Science and Technology
|
September 30, 2021
Effects of Aerobic Exercise on Systemic Insulin Degludec Concentrations in People with Type 1 Diabetes
David Herzig, Michael Groessl, Mario Álvarez-Martínez, et al.
Analytical Chemistry
|
August 24, 2019
Quantitative Fragmentation Model for Bottom-Up Shotgun Lipidomics
Kai Schuhmann, HongKee Moon, Henrik Thomas, et al.
Eclinicalmedicine
|
April 15, 2024
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial
Paolo Mulatero, Gregoire Wuerzner, Michael Groessl, et al.
Scientific Reports
|
May 7, 2021
Steroid hormone bioavailability is controlled by the lymphatic system
Rahel Klossner, Michael Groessl, Nadine Schumacher, et al.
Molecular & Cellular Proteomics : MCP
|
April 25, 2025
Landscape of Steroid Dynamics in Pregnancy: Insights From the Maternal-Placental-Fetal Unit and Placental Models
Rona Karahoda, Therina Du Toit, Barbara Fuenzalida, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 16, 2011
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine
Oliver Brandt, Michael Mildner, Alexander E Egger, et al.
Journal of Medicinal Chemistry
|
April 4, 2007
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity
Michael Groessl, Erwin Reisner, Christian G Hartinger, et al.
Chemistry & Biodiversity
|
October 31, 2008
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients
Christian G Hartinger, Michael A Jakupec, Stefanie Zorbas-Seifried, et al.
Page
of 7